Delayed allergy-like reactions to X-ray contrast media: Mechanistic considerations

European Radiology

Volumn 10, Issue 12, 2000, Pages 1965-1975

  Christiansen, C ^a   Pichler, W J ^b   Skotland, T ^a  

^a NYCOMED IMAGING AS   (Norway)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Allergy like reactions; Delayed reactions; Pathophysiological mechanisms; X ray contrast media

Indexed keywords

ANTIHISTAMINIC AGENT; CONTRAST MEDIUM; CORTICOSTEROID; INTERLEUKIN 2;

ALLERGY; ANGIONEUROTIC EDEMA; CONTRAST ENHANCEMENT; DELAYED HYPERSENSITIVITY; DISEASE COURSE; ETHNOLOGY; HUMAN; JAPAN; OSMOLALITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; T LYMPHOCYTE ACTIVATION; URTICARIA; X RAY;

CONTRAST MEDIA; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; IODINE COMPOUNDS; OSMOLAR CONCENTRATION; RISK FACTORS;

EID: 0033660060     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300000543     Document Type: Review

References (94)

1. High-osmolar and low-osmolar contrast media. An update on frequency of adverse reactions
2. Risk factors, prophylaxis and therapy of X-ray contrast media reactions
3. Visipaque: A step forward. A historical review
4. An overview of the clinical pharmacokinetics of X-ray contrast media
5. Late allergy-like reactions following vascular administration of radiography contrast media
6. Isovist-280: Clinical data and delayed allergy-like reactions
7. Frequency of late allergy-like adverse reactions following injection of intravascular non-ionic contrast media. A retrospective study comparing a non-ionic monomeric contrast medium with a non-ionic dimeric contrast medium
8. Delayed adverse reactions to nonionic monomeric contrast-enhanced media
9. Late adverse reactions to non-ionic contrast media: A cohort analytic study
10. Problems in surveying the incidence of delayed adverse reactions to contrast media. Delayed symptoms due to factors other than contrast media
11. Delayed allergy-like reactions in patients: Monomeric and dimeric contrast media compared with plain CT
12. Late adverse reactions to nonionic contrast media
13. Time pattern of allergic reactions to drugs
14. Drug eruptions. A series of 464 cases in the Department of Dermatology, University of Turku, Finland, during 1966-1970
15. Cutaneous drug reactions. An attempt to quantitative estimation
16. Comprehensive hospital drug monitoring (CHDM): Adverse skin reactions, a 20-year survey
17. Drug induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15 438 consecutive inpatients, 1975 to 1982
18. Acute and late adverse reactions to low-osmolal contrast media
19. Fixed bullous drug eruption due to iohexol
20. Fixed drug eruption caused by iopamidol, a contrast medium
21. Multiple fixed drug eruption caused by iomeprol (Iomeron), a nonionic contrast medium
22. Delayed life-threatening reaction to non-ionic contrast media
23. Fatal acute vasculitis after high-dose urography with iohexol
24. Hydrallazine predisposes to acute cutaneous vasculitis following urography with iopamidol
25. Fatal Stevens-Johnson syndrome following urography with iopamidol in systemic lupus erythematosus
26. An autopsy case of malignant lymphoma with Lyell's syndrome
27. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media
28. Large-scale study of delayed adverse events to non-ionic contrast medium, iohexol: Incidence and risk factors of adverse events following non-interventional radiography
29. Delayed allergy-like reactions to X-ray contrast media. Problem statement exemplified with iotrolan (Isovist) 280
30. The study of delayed adverse events and adverse reactions to a non-ionic contrast medium; iohexol: Adverse events and adverse reactions following interventional radiography with iohexol
31. Drug eruption caused by nonionic iodinated X-ray contrast media
32. Delayed-type hypersensitivity to a nonionic, radiopaque contrast medium
33. Adverse events with radiographic contrast agents: Results of the SCVIR Contrast Agent Registry
34. The use of io-hexol in patients with previous reactions to ionic contrast material. A multicenter clinical trial
35. Gender risk for anaphylactoid reaction to radiographic contrast media
36. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: Evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media
37. Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration
38. Contrast medium 'recalls' interleukin-2 toxicity
39. Atypical contrast reactions associated with systemic interleukin-2 therapy
40. Metastatic renal cell cancer: Interleukin-2 toxicity induced by contrast agent injection
41. Delayed reactions to contrast media after interleukin-2 immunotherapy
42. Adverse reactions to intravenous contrast media in patients treated with interleukin-2
43. Delayed hypersensitivity reaction to the non-ionic contrast medium iopromid
44. Drug eruption due to nonionic X-ray contrast medium, iotrolan. Cases with immediate or delayed onset of skin rash
45. A case of drug eruption caused by Omnipaque (iohexol)
46. Late-type allergy to the X-ray contrast medium Solutrast (iopamidol)
47. Late skin test reactions to radiocontrast medium
48. Late phase allergic reaction to a CT contrast medium (iotrolan)
49. Drug eruption due to iohexol (Article in Japanese)
50. Radiologic contrast media
51. Immunologic basis for adverse reactions to radiographic contrast media
52. Acute renal failure after intravenous urography: Detection of antibodies against contrast media
53. Sudden death caused by interaction between a macroglobulin and a divalent drug
54. Immune-mediated hemolysis associated with the administration of a radiographic contrast medium
55. IgE-mediated adverse reactivity to a radiographic contrast medium
56. Case report: Recurrent anaphylactic shock to radiographic contrast media. Evidence supporting an exceptional IgE-mediated reaction
57. Mechanisms of severe, immediate reactions to iodinated contrast material
58. Detection of IgE anti-body to a radiocontrast medium
59. Antibodies to radiographic contrast agents. Induction and characterization of rabbit antibody
60. Failure to induce hypersensitivity reactions to opaque contrast media analogs in guinea pigs
61. Contrast media reactions: Experimental evidence against the allergy theory
62. The lack of immunogenicity of iotrolan
63. Benign transient eosinophilia following intravenous urography
64. Eosinophilia caused by iodinated radiographic contrast media
65. Delayed hypersensitivity to X-ray CM: Possible mechanisms and models
66. Physico-chemical characteristics of Isovist-280 and its immunogenic potential
67. Can contrast media act as 'pseudoantigens'?
68. Evidence against molecular aggregates in concentrated solutions of X-ray contrast media
69. Serological methods in the diagnosis and management of human allergic disease
70. Facts about acetaldehyde and bisdiazotized benzidine: Literature overview
71. Immunological physiopathology of cutaneous adverse drug reactions
72. Role of T cells in drug allergies
73. T-cell reaction to local anaesthetics: Relationship to angioedema and urticaria after subcutaneous application: Patch testing and LTT in patients with adverse reaction to local anaesthetics
74. T-cell mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction
75. Role of drug disposition in drug hypersensitivity: A chemical, molecular, and clinical perspective
76. + T cell clones
77. Direct MHC-dependent presentation of the drug sulfomethoxazole to human αβ T cell clones
78. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human αβ T lymphocytes
79. + T cells
80. Allergic reactions to contrast media: Accumulated evidence
81. In vitro interleukin-5 (IL-5) production by peripheral blood mononuclear cells from patients with drug hypersensitivity
82. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfamethozazole, phenytoin and carbamazepine
83. Characterization of lidocaine specific T cells
84. High IL-5 production by drug specific T-cell clones
85. Eosinophilia in transgenic mice expressing interleukin 5
86. The eosinophil
87. Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia
88. Facial edema and eosinophilia. Evidence for eosinophil degranulation
89. A current perspective on the role of eosinophils in dermatologic diseases
90. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media
91. Complement and contrast material reactors
92. In vivo study of the complement system during infusion of radiographic contrast media
93. Immediate hypersensitivity reactions to beta-lactam antibiotics
94. Immediate hypersensitivity reactions to penicillin and related antibiotics